Within the first year of diagnosis, 1.9% of all deaths were CVM-related and this percentage increased from 1.7% in year two to 2.7% in year three, to 3.4% in year four, to 7.7% in year five, and to 10.0% after 5 years, showing an increasing trend for percentage of deaths due to CVM along with patients' survival time.
← all excerpts
Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study.
1
—
—